Search the Newsreel

CapsoVision (CV) Stock Rich Valuation Meets Widening Losses

The 5 Most Interesting Analyst Questions From Gray Television’s Q2 Earnings Call

Gray Television (GTN) exceeded Q2 earnings expectations, driven by strong political and digital advertising and successful station integration. The article highlights key analyst questions from the earnings call, focusing on topics like net retransmission revenue, future EBITDA, FCC ownership rule changes, debt reduction strategies, …

Vishay Intertechnology Inc (VSH) Stock Up 5.3% but GF Value Says Overvalued -- GF Score: 76/100

Vishay Intertechnology Inc (VSH) saw its stock rise 5.3% to $35.08, but GuruFocus's GF Value™ suggests it is 68.9% overvalued at $20.77. The company holds an above-average GF Score™ of 76/100, yet its valuation rank is low due to a high P/E ratio of …

Vistagen Therapeutics (VTGN): OrbiMed reports 0.0% beneficial ownership in latest 13G/A

Annovis Bio (NYSE:ANVS) Posts Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Annovis Bio reported a Q2 2026 EPS of $(0.40), exceeding the analyst estimate of $(0.45), despite widening its net loss to $14.8 million primarily due to a 131% increase in R&D expenses. The company achieved full enrollment of 850 patients in its pivotal Phase …

VisionWave Holdings (VWAV) terminates 51% Meteor Aerospace acquisition valued at $40M

VisionWave Holdings (VWAV) has terminated its binding agreement to acquire a 51% stake in Meteor Aerospace Ltd., an acquisition valued at $40 million. The decision came after VisionWave completed its due diligence review. The company confirmed that no shares were issued, no consideration was …

VisionWave Holdings ends acquisition agreement with Meteor Aerospace

VisionWave Holdings Inc. (NASDAQ:VWAV) announced the termination of its agreement to acquire a majority stake in Meteor Aerospace Ltd. The decision followed a due diligence review, and no shares were issued nor were any early termination penalties incurred. This comes after previous news of …

Keen Vision Acquisition (KVAC) hit by Nasdaq delisting and going-concern warning

Keen Vision Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Bill Ackman Vs. Buffett Successor: Mastercard, Visa Stock Battle Lines Drawn — Who Wins?

Bill Ackman's Pershing Square has invested in Visa and Mastercard, stocks that Warren Buffett's successor, Greg Abel, recently sold from Berkshire Hathaway's portfolio. Ackman's investment appears to be an early win as both Visa and Mastercard stocks have seen significant gains since the end …

Cinevista Ltd Reports Very Positive Financial Trend Amid Margin Expansion

VisionWave Holdings (NASDAQ: VWAV) flags steep Q2 loss and late 10-Q filing

ANVS: Net loss rose sharply as clinical trial costs surged, with cash runway only through Q4 2026

Annovis Bio (ANVS) reported a significant widening of its net loss to $14.8M for Q2 2026 and $32.4M for the first half, primarily due to increased R&D and G&A expenses as late-stage clinical trials advanced. The company's current cash of $18.7M is projected to …

ANVS: Alzheimer's Phase 3 trial fully enrolled; R&D costs and net loss per share increased year-over-year

Annovis Bio (ANVS) has fully enrolled its pivotal Alzheimer's Phase 3 trial, with topline data anticipated in Q1 2027. The company experienced a sharp increase in research and development expenses, leading to a higher net loss per share year-over-year. Additionally, enrollment continues for the …

Vistagen Therapeutics (VTGN) investor Chen Yu reports 6.7% warrant-based stake

Chen Yu, through TCG Crossover funds, has reported a 6.7% warrant-based stake in Vistagen Therapeutics (VTGN) via an amended Schedule 13G/A filing. TCG Crossover I holds 1.8% and TCG Crossover II holds 5.1%, with Chen Yu being the sole managing member of both general …

Vistagen Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026

Rubric Capital discloses 3.9M-share Enovis (ENOV) position in Schedule 13G

Rubric Capital Management LP and David Rosen have jointly filed a Schedule 13G, disclosing beneficial ownership of 3,900,000 shares of Enovis Corporation (ENOV) common stock. This position represents 6.78% of the company's outstanding shares, based on 57,562,603 shares as of May 1, 2026. Both …

Bill Ackman Just Bought Visa Stock. What Barchart Options Data Says Could Come Next for V Investors.

Visa Inc gold card-by hatchpong via iStock Bill Ackman's Pershing Square disclosed a new position in Visa (V) in its semiannual report released on Aug. 13 as part of the hedge fund's most sweeping portfolio expansion in recent years. The Visa stake was one …

Vistagen (VTGN) narrows quarterly loss, eyes FDA path after mixed fasedienol data

Vistagen (VTGN) reported a narrower net loss of $13.0 million for Q1 FY2027, an improvement from $15.1 million in the prior-year quarter, largely due to increased revenue and reduced R&D and G&A expenses. While its lead drug fasedienol missed its primary endpoint in the …

National Vision Holdings Inc (EYE) Stock News Today

VistaGen Therapeutics earnings missed by $0.05, revenue topped estimates

How (GTN.A) Movements Inform Risk Allocation Models

This article analyzes Gray Television Inc. Class A (GTN.A) using AI models, indicating weak sentiment across all time horizons and supporting a short bias. It outlines institutional trading strategies including position, momentum, and risk hedging, along with multi-timeframe signal analysis to inform risk allocation …

Vistagen Therapeutics Releases Q1 2027 Financial Results

Vistagen Therapeutics reported a narrower loss for Q1 fiscal 2027, with a basic and diluted loss of $0.30 per share and a net loss of $13.0M. The company saw a significant revenue increase to $1.5M, up 504.9% year-over-year, as it continues to develop therapies …

HSBC Stock And 2 Global Bank Picks for Trade and Rate Rule Changes

This article identifies three global banking stocks—Banco Bilbao Vizcaya Argentaria (BBVA), Banco Santander (SAN), and HSBC Holdings (HSBA)—that are well-positioned to navigate the evolving landscape of trade, interest rates, and compliance regulations. These banks offer diversified operations, significant digital banking investments, and varying risk-reward …

Vistagen Reports Narrower Q1 Loss; Plans FDA Meeting On Fasedienol Development Path

(RTTNews) - Vistagen Therapeutics Inc. (VTGN), a late clinical-stage biopharmaceutical company developing intranasal pherine therapies for neuropsychiatric and other disorders, reported first quarter fiscal 2027 results and provided a corporate update. Vistagen is developing rapid-onset intranasal pherine product candidates designed to target nose-to-brain neurocircuitry. …

Raj Television Network Ltd is Rated Strong Sell

Highbridge Capital (ANVS) discloses 6.1% Annovis Bio stake tied to 2.78M warrant shares

Highbridge Capital Management, LLC has disclosed a beneficial ownership of 6.1% in Annovis Bio, Inc., which is tied to 2,775,578 shares of common stock issuable upon the exercise of warrants. This stake is calculated based on 42,541,868 outstanding common shares after a referenced offering …

Legal & General reports 4.9% Ziff Davis (ZD) ownership position

Legal & General Group Plc and its affiliated investment entities have reported a 4.9% beneficial ownership in Ziff Davis, Inc., amounting to 1,800,921 shares as of June 30, 2026. This ownership is held with shared voting and dispositive power across various asset management affiliates …

Annovis Bio Sees Unusually Large Options Volume (NYSE:ANVS)

Annovis Bio (NYSE:ANVS) experienced unusual options trading volume on Friday, with traders buying 3,595 put options, a 139% increase over its typical daily volume. Despite a "Moderate Buy" consensus rating from analysts, the stock is trading near its 52-week low. The company recently reported …

Can NVST Sustain Its 2026 Guidance Boost as Margins Keep Expanding?

Envista Holdings Corporation NVST raised its 2026 outlook after a stronger first half, putting greater emphasis on whether recent sales and profit gains can carry through the rest of the year. Higher revenue expectations and expanding margins support the earnings recovery. China pricing changes, …

MicroVision Prices $17 Million Public Offering to Fund Operations and Capital Spending

MicroVision, Inc. (Nasdaq: MVIS) has priced a $17 million public offering consisting of 6.8 million units, each unit comprising one share of common stock and one warrant. This financing aims to provide capital for working capital, capital expenditures, and general corporate purposes as the …

Envision Greenwise Sets Auditor Reappointment and Fee Range Ahead of AGM

Implied Volatility Surging for Banco Bilbao Stock Options

Implied volatility for Banco Bilbao Vizcaya Argentaria, S.A. (BBVA) stock options, particularly the Sept. 18, 2026 $25.00 Call, is surging, indicating that the market anticipates a significant price movement. Despite this, analysts currently rate Banco Bilbao as a Zacks Rank #4 (Sell), suggesting a …

MicroVision prices $17M public offering at $2.50 per unit

MicroVision, Inc. has announced the pricing of a public offering consisting of 6,800,000 units at $2.50 per unit, aiming to raise approximately $17.0 million in gross proceeds. Each unit includes one share of common stock and one warrant, exercisable at $2.50 per share for …

MicroVision Announces Pricing of $17.0 Million Public Offering

MicroVision, Inc. has announced the pricing of a public offering of 6,800,000 units at $2.50 per unit, aiming to raise approximately $17.0 million in gross proceeds. Each unit consists of one share of common stock and one warrant to purchase another share. The company …

Royal Bank of Canada Grows Position in Visteon Corporation $VC

Royal Bank of Canada significantly increased its stake in Visteon Corporation (NASDAQ:VC) by 103.2% in the first quarter, now owning 45,410 shares valued at $4.14 million. This move comes as institutional investors collectively hold 99.71% of Visteon's stock. Despite missing quarterly EPS estimates, the …